Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial (HOST-IDEA)
Sponsor: B. Braun Korea Co., Ltd.
A PHASE4 clinical study on Non-ST Segment Elevation Myocardial Infarction and Stable Angina, this trial is completed. The trial is conducted by B. Braun Korea Co., Ltd. and has accumulated 9 data snapshots since 2016. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Feb 2023 — Jul 2024 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
-
Dec 2022 — Feb 2023 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
▶ Show 4 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Recruiting PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Recruiting PHASE4
-
Jul 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Jul 2017 [monthly]
Recruiting PHASE4
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- B. Braun Korea Co., Ltd.
- Seoul National University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .